SCHEMBL30848281

SCHEMBL30848281

COc1cc(NS(=O)(=O)c2cnn(-c3ccnc(C(F)(F)F)c3)c2)c2c(cnn2C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC40A1 Q9NP59 8/20 0.40
▸ MEN1 O00255 5/20 0.40
▸ KMT2A Q03164 5/20 0.40
▸ TDP1 Q9NUW8 5/20 0.40
▸ POLB P06746 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ CXCR2 P25025 1/20 0.39
▸ AGTR1 P30556 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ CKS1B P61024 1/20 0.36
▸ SKP2 Q13309 1/20 0.36
▸ NFKBIA P25963 1/20 0.34
▸ GLO1 Q04760 1/20 0.34
▸ RXRA P19793 1/20 0.34
▸ GRIN1 Q05586 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27132781 1.00 SLC40A1 (0.40) SLC40A1MEN1KMT2ATDP1POLB
SCHEMBL27132706 0.89 SLC40A1 (0.38) SLC40A1RXRAGRIN1GRIN2B
SCHEMBL27133577 0.89 SLC40A1 (0.40) SLC40A1CKS1BSKP2RXRAGRIN1
SCHEMBL30847957 0.89 SLC40A1 (0.38) SLC40A1RXRAGRIN1GRIN2B
SCHEMBL27138104 0.88 SLC40A1 (0.34) SLC40A1MEN1KMT2ATDP1RXRA
SCHEMBL27133468 0.87 SLC40A1 (0.37) SLC40A1RXRAGRIN1GRIN2B
SCHEMBL30847967 0.87 SLC40A1 (0.37) SLC40A1RXRAGRIN1GRIN2B
SCHEMBL27132481 0.86 SLC40A1 (0.43) SLC40A1KMT2ATDP1LMNAMAPT
SCHEMBL27139585 0.85 SLC40A1 (0.43) SLC40A1MEN1KMT2ATDP1POLB
SCHEMBL30847991 0.84 PIK3CA (0.36) RXRAGRIN1GRIN2BPIK3CAMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4577536-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY Hotspot Therapeutics, Inc. (US) 2025-07-02 — — EP disclosed
WO-2024044730-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY HOTSPOT THERAPEUTICS, INC. (US) 2024-02-29 — — WO disclosed
Send feedback